Skip to main content
SpringerLink
Log in

No evidence for reduced 25-hydroxyvitamin D serum levels in melanoma patients

  • Letter to the Editor
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case-control study of cutaneous malignant melanoma. II Importance of UV-light exposure. Int J Cancer 42: 319-324.

    Google Scholar 

  2. Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19: 614-622.

    Google Scholar 

  3. Garland CF, Comstock GW, Garland FC, et al. (1989) Serum 25-hydroxyvitamin D and colon cancer: eight year prospective study. Lancet 1176-1178.

  4. Garland CF, Garland FC, Gorham ED (1991) Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr 54: 193S-201S.

    Google Scholar 

  5. Grant WB (2002) An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875.

    Google Scholar 

  6. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7: 391-395.

    Google Scholar 

  7. Reichrath J (2001) Will analogs of 1,25-dihydroxyvitamin D3 (calcitriol) open a new era in cancer therapy? Onkologie 24: 128-133.

    Google Scholar 

  8. Osborne JE, Hutchinson PE (2002) Vitamin D and systemic cancer: is this relavant to malignant melanoma? Br J Dermatol 147: 197-213.

    Google Scholar 

  9. Green A, Siskind V (1983) Geographical distribution of cutaneous melanoma in Queensland. Med J Aust 1: 407-410.

    Google Scholar 

  10. Elwood JM, Gallagher RP, Hill GB, Pearson JC (1985) Cutaneous melanoma in relation to intermittent and constant sun exposure-the Western Canada Melanoma Study. Int J Cancer 35: 427-433.

    Google Scholar 

  11. Westerdahl J, Olsson H, Mosback A, et al. (1995) Is the use of sunscreensa risk factor for melanoma? Melanoma Res 5: 59-65.

    Google Scholar 

  12. Cornwell ML, Comstock GW, Holick MF, Bush TL (1992) Prediagnostic serum levels of 1,25-dihydroxyvitamin D and malignant melanoma. Photodermatol Photoimmunol Photomed 9(3): 109-112.

    Google Scholar 

  13. Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69(5): 842-856.

    Google Scholar 

  14. Holick MF (2001) Sunlight ‘D’ ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 357: 4-6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, The Saarland University Hospital, 66421, Homburg/Saar, Germany

    Jörg Reichrath & Kerstin Querings

Authors
  1. Jörg Reichrath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kerstin Querings
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reichrath, J., Querings, K. No evidence for reduced 25-hydroxyvitamin D serum levels in melanoma patients. Cancer Causes Control 15, 97–98 (2004). https://doi.org/10.1023/B:CACO.0000016676.23024.e8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:CACO.0000016676.23024.e8

Keywords

Search

Navigation